LindaRDuskaMD

Clinical Trials

• Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma Start of enrollment: 2006 Feb 01

  Unknown status

  Phase 2

• Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2009 Oct 28

  Completed

  Phase 1

• Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Apr 05

  Completed

  Phase 1

• Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy Start of enrollment: 2010 Nov 01

  Completed

  Phase 2

• A Prospective Trial of COXEN Chemotherapy Prediction Start of enrollment: 2010 Oct 01

  Withdrawn

  Not Applicable

• Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer Start of enrollment: 2012 Jan 01

  Completed

  Early Phase 1

• A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer Start of enrollment: 2012 Sep 01

  Completed

  Phase 2

• Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer Start of enrollment: 2013 Apr 01

  Completed

  Phase 3

• Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer Start of enrollment: 2017 Oct 11

  Completed

  Early Phase 1

• Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2018 Oct 12

  Active, not recruiting

  Phase 2

• A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) Start of enrollment: 2019 Mar 20

  Completed

  Phase 2

• Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Start of enrollment: 2019 May 14

  Active, not recruiting

• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer Start of enrollment: 2021 Feb 22

  Active, not recruiting

  Phase 3

• Join now to see all